N

NewGLab Pharma Co Ltd
KOSDAQ:214870

Watchlist Manager
NewGLab Pharma Co Ltd
KOSDAQ:214870
Watchlist
Price: 6 915 KRW -27.44% Market Closed
Market Cap: 323.6B KRW
Have any thoughts about
NewGLab Pharma Co Ltd?
Write Note

NewGLab Pharma Co Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

NewGLab Pharma Co Ltd
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
N
NewGLab Pharma Co Ltd
KOSDAQ:214870
Cash from Operating Activities
-â‚©310.9m
CAGR 3-Years
75%
CAGR 5-Years
61%
CAGR 10-Years
N/A
V
Vidente Co Ltd
KOSDAQ:121800
Cash from Operating Activities
-â‚©12.9B
CAGR 3-Years
N/A
CAGR 5-Years
-35%
CAGR 10-Years
N/A
T
Tovis Co Ltd
KOSDAQ:051360
Cash from Operating Activities
â‚©67.6B
CAGR 3-Years
50%
CAGR 5-Years
38%
CAGR 10-Years
11%
F
Furonteer Co Ltd
KOSDAQ:370090
Cash from Operating Activities
â‚©12.7B
CAGR 3-Years
N/A
CAGR 5-Years
31%
CAGR 10-Years
N/A
P
Park Systems Corp
KOSDAQ:140860
Cash from Operating Activities
â‚©30.7B
CAGR 3-Years
28%
CAGR 5-Years
51%
CAGR 10-Years
N/A
W
Woori Technology Inc
KOSDAQ:032820
Cash from Operating Activities
â‚©16.7B
CAGR 3-Years
315%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

NewGLab Pharma Co Ltd
Glance View

Market Cap
323.6B KRW
Industry
Electrical Equipment

NewGLAB Pharma Co., Ltd. engages in the manufacture of closed-circuit television camera and equipment. The company is headquartered in Bucheon, Gyeonggi-Do. The company went IPO on 2015-10-13. The firm's product portfolio consists of general analog cameras that used for CCTVs, high definition (HD) analog cameras, HD-serial digital interface (SDI) cameras, extend (EX)-SDI cameras, internet protocol (IP) cameras that used for network CCTVs, digital video recorders (DVRs) that used for image storage devices, network video recorders (NVRs) and others. In addition, the Company is involved in the business of 5G smartphone distribution. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
84.39 KRW
Overvaluation 99%
Intrinsic Value
Price
N

See Also

What is NewGLab Pharma Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
-310.9m KRW

Based on the financial report for Sep 30, 2024, NewGLab Pharma Co Ltd's Cash from Operating Activities amounts to -310.9m KRW.

What is NewGLab Pharma Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
61%

Over the last year, the Cash from Operating Activities growth was 97%. The average annual Cash from Operating Activities growth rates for NewGLab Pharma Co Ltd have been 75% over the past three years , 61% over the past five years .

Back to Top